2nd Quarter - Report
BROWN RUDNICK LLP for HOSPIRA, INC.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1548 - The Pathway to Biosimilars Act; S. 726 & H.R. 1427 - The Promoting Innovation and Access to Life-Savings Medicine Act; S.301 - Physician Payments Sunshine Act of 2009; Issues relating to drug pedigree; H.R. 1346 & S. 540 - Medical Device Safety Act of 2009; The Affordable Health Choices Act relating to biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.